Article citationsMore>>

Urata, Y., Uesato, R., Tanaka, D., Kowatari, K., Nitobe, T., Nakamura, Y. and Motomura, S. (2011) Prevalence of Reactivation of Hepatitis B Virus Replication in Rheumatoid Arthritis Patients. Modern Rheumatology, 21, 16-23.
https://doi.org/10.3109/s10165-010-0337-z

has been cited by the following article:

• TITLE: Suppression of Methotrexate-Induced Elevations in the Serum Alanine Aminotransferase Level of Patients with Rheumatoid Arthritis Who Had Prior Hepatitis B Infection

  AUTHORS: Osamu Noguchi, Yukio Nakamura, Hiroyuki Kato

  KEYWORDS: Rheumatoid Arthritis, De Novo Hepatitis B, MTX-Induced Liver Injury, ALT, Biological Agents

  JOURNAL NAME: Health, Vol.10 No.5, May 15, 2018

  ABSTRACT: Background: Hepatitis after the reactivation of hepatitis B virus (HBV) has been recognized serious in the patients with rheumatoid arthritis (RA) treated with biologics. Objectives: The objective of the present study was to search some common background which might be relevant to the host factors that provoke such a serious hepatitis. Methods: We retrospectively collected and analyzed all data of serum alanine aminotransferase (ALT) levels in selected patients with RA at random. Results: A significant association (P P P = 0.73) in the anti-HBcAb-positive RA group. In addition, the anti-HBcAb-positive RA patients showed significantly lower mean serum level of ALT (P P Conclusions: The anti-HBcAb-positive RA group showed the suppression of MTX-induced elevations in serum ALT level. However, this suppression was not found in patients experienced in the treatment with biologics, although it was preserved in those who had not experienced biologics. Failure of this suppressive mechanism of ALT in anti-HBcAb-positive RA patients treated with biologics could be possibly associated with serious hepatitis after the reactivation of HBV infection.